Morgan Stanley’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75K | Buy |
|
|||||
|
2025
Q1 | $71.5K | Buy |
|
|||||
|
2024
Q4 | $209K | Sell |
|
|||||
|
2024
Q3 | $251K | Buy |
|
|||||
|
2024
Q2 | $100K | Buy |
|
|||||
|
2024
Q1 | $123K | Sell |
|
|||||
|
2023
Q4 | $252K | Buy |
|
|||||
|
2023
Q3 | $47.3K | Sell |
|
|||||
|
2023
Q2 | $110K | Buy |
|
|||||
|
2023
Q1 | $71.4K | Buy |
|
|||||
|
2022
Q4 | $10K | Buy |
|